Dhilhani Faleel, Ahmed Elzanaty, Vaishnavi Aradhyula, Rohit Vyas, Prabhatchandra R. Dube, Steven T. Haller, Rajesh Gupta, David J. Kennedy, Samer J. Khouri
{"title":"Machine Learning Analysis of Identifies Polyunsaturated Fatty Acid Metabolites Predictive of Adverse Outcomes In Heart Failure with Preserved Ejection Fraction Patients","authors":"Dhilhani Faleel, Ahmed Elzanaty, Vaishnavi Aradhyula, Rohit Vyas, Prabhatchandra R. Dube, Steven T. Haller, Rajesh Gupta, David J. Kennedy, Samer J. Khouri","doi":"10.46570/utjms.vol11-2023-951","DOIUrl":null,"url":null,"abstract":"which molecules were associated with future risk of either all cause death or a combined adverse outcome of death or rehospitalization in the setting of HFpEF. Results: In patients with HFpEF, increased levels of 9(10)-Epome, 15(R)-PGE1, 17-oxoRvD1, TXB3, RvD3, 5(S),15(S)-DiHETE, and 11dh-2,3-dinor TXB2 at baseline were predictive of all cause mortality (all p<0.05). Increased baseline levels of 8-oxoRvD1, MaR1(n-3DPA), PGE3, and 5,6-DiHETrE were predictive of the combined adverse outcome of death or rehospitalization (all p<0.05). Conclusion: These findings support the hypothesis that distinct PUFA metabolites play a significant role in mediating cardiovascular disease in HFpEF. Our study introduces a novel lipidomics framework for the diagnostic and prognostic assessment of cardiovascular risk in HFpEF patients.","PeriodicalId":220681,"journal":{"name":"Translation: The University of Toledo Journal of Medical Sciences","volume":"5 14","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translation: The University of Toledo Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46570/utjms.vol11-2023-951","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
which molecules were associated with future risk of either all cause death or a combined adverse outcome of death or rehospitalization in the setting of HFpEF. Results: In patients with HFpEF, increased levels of 9(10)-Epome, 15(R)-PGE1, 17-oxoRvD1, TXB3, RvD3, 5(S),15(S)-DiHETE, and 11dh-2,3-dinor TXB2 at baseline were predictive of all cause mortality (all p<0.05). Increased baseline levels of 8-oxoRvD1, MaR1(n-3DPA), PGE3, and 5,6-DiHETrE were predictive of the combined adverse outcome of death or rehospitalization (all p<0.05). Conclusion: These findings support the hypothesis that distinct PUFA metabolites play a significant role in mediating cardiovascular disease in HFpEF. Our study introduces a novel lipidomics framework for the diagnostic and prognostic assessment of cardiovascular risk in HFpEF patients.